SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,191.76 549.28
(1.06%)

Dow Jones

7,764.37 24.43
(0.32%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,879.96 39.61
(0.37%)

Forex

USD-INR

95.08 -0.14
(-0.15%)

EUR-INR

106.23 -0.27
(-0.26%)

GBP-INR

125.74 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

43.3828165

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

13.17

209.68

EPS(TTM)

Face Value()

Div & Yield %

10.08

0.53

Back

Grauer & Weil (India) consolidated net profit declines 8.71% in the June 2026 quarter

Aug 04,2026

Net profit of Grauer & Weil (India) declined 8.71% to Rs 39.81 crore in the quarter ended June 2026 as against Rs 43.61 crore during the previous quarter ended June 2025. Sales rose 17.93% to Rs 298.68 crore in the quarter ended June 2026 as against Rs 253.26 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	298.68	253.26	18
OPM %	16.13	20.76	-
PBDT	59.95	64.48	-7
PBT	53.58	58.40	-8
NP	39.81	43.61	-9

74,729.27 413.66 ( 0.56%)

52,191.76 549.28 (1.06%)

7,764.37 24.43 (0.32%)

65,489.63 1,063.68 (1.65%)

10,879.96 39.61 (0.37%)

95.08 -0.14 (-0.15%)

106.23 -0.27 (-0.26%)

125.74 -0.30 (-0.24%)

0.60 0.00 (-0.23%)